Abrogation of USP9X is a potential strategy to decrease PEG10 levels and impede tumor progression in cutaneous T-cell lymphoma
Article in Journal of Investigative Dermatology (April 2024)
The most recent citing publications are shown below. View all 13 publications that cite this research output on Dimensions.
Cellular functions, molecular signalings and therapeutic applications: Translational potential of deubiquitylating enzyme USP9X as a drug target in cancer treatment
Article in Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (April 2024)
The role of kinesin family members in hepatobiliary carcinomas: from bench to bedside
Article in Biomarker Research (March 2024)